BSE: 524348 | NSE: AARTIDRUGS | Pharmaceuticals & Drugs | Small Cap
1. Is Aarti Drugs Ltd a good quality company?
Past 10 year's financial track record analysis by Moneyworks4me indicates that Aarti Drugs Ltd is a average quality company.
2. Is Aarti Drugs Ltd undervalued or overvalued?
The key valuation ratios of Aarti Drugs Ltd's currently when compared to its past seem to suggest it is in the Fair zone.
3. Is Aarti Drugs Ltd a good buy now?
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Aarti Drugs Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
Value Creation ⓘ
Value Creation Index Colour Code Guide ⓘ
|ROCE % ⓘ||12.5%||9.3%||18%||12.8%||12.6%||11.6%||11.5%||15.8%||25.9%||15.7%||-|
|Value Creation Index ⓘ||-0.1||-0.3||0.3||-0.1||-0.1||-0.2||-0.2||0.1||0.9||0.1||-|
Growth Parameters ⓘ
Growth Parameters Colour Code Guide ⓘ
|YoY Gr. Rt. %||-||4.7%||118.9%||3.9%||4.9%||4.1%||25.5%||15.7%||19.3%||15.5%||-|
|Adj EPS ⓘ||2.9||2.5||8||7.1||8.4||8.7||9.2||14.8||29.8||22.1||18|
|YoY Gr. Rt. %||-||-16.3%||224.4%||-11.2%||18.8%||3.7%||5.8%||60.6%||101.1%||-25.8%||-|
|BVPS (₹) ⓘ||15.1||16.8||31.8||36.9||41.9||48.3||57.6||70||98||111.9||128.8|
|Adj Net Profit ⓘ||28.4||23.9||77.3||68.7||80.3||82.3||87.1||138||278||205||166|
|Cash Flow from Ops. ⓘ||59.1||20.6||105||133||175||69.8||143||251||155||69.6||-|
|Debt/CF from Ops. ⓘ||3.2||13||4.3||3.6||2.7||7.8||3.5||1.5||2.2||7.7||-|
CAGR Colour Code Guide ⓘ
|9 Years||5 Years||3 Years||1 Years|
|Adj EPS ⓘ||25.2%||21.3%||33.8%||-25.8%|
Key Financial Parameters ⓘ
Performance Ratio Colour Code Guide ⓘ
|Return on Equity % ⓘ||21.1||15.4||32.8||20.7||21.2||19.2||17.4||23.1||35.5||21||14.9|
|Op. Profit Mgn % ⓘ||17.3||13.8||15.7||15.8||15.9||16.2||13.5||14.7||20.4||13.4||11.3|
|Net Profit Mgn % ⓘ||6||4.7||7||6||6.7||6.6||5.6||7.7||12.9||8.2||6.1|
|Debt to Equity ⓘ||1.3||1.6||1.5||1.4||1.2||1.2||0.9||0.6||0.4||0.5||0.2|
|Working Cap Days ⓘ||141||156||121||162||162||191||178||170||165||180||181|
|Cash Conv. Cycle ⓘ||81||90||61||81||76||94||91||89||82||99||68|
Sales growth is growing at healthy rate in last 3 years 16.82%
Net Profit is growing at healthy rate in last 3 years 33.81%
Return on Equity has declined versus last 3 years average to 14.90%
Sales growth is not so good in last 4 quarters at 9.35%
|TTM EPS (₹)||16.5||18|
|TTM Sales (₹ Cr.)||2,498||2,716|
|BVPS (₹.) ⓘ||120.3||128.8|
|Reserves (₹ Cr.) ⓘ||1,022||1,100|
|From the Market|
|52 Week Low / High (₹)||310.80 / 511.65|
|All Time Low / High (₹)||0.57 / 1025.00|
|Market Cap (₹ Cr.)||4,224|
|Equity (₹ Cr.)||92.6|
|Face Value (₹)||10|
|Industry PE ⓘ||37.9|
Aarti Drugs Ltd. was established in the year 1984 and forms part of $900 Million Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations.
Over the years, the Company has been able to carve a niche for itself and is looking forward to expand the volumes. With the government initiative to encourage private health insurance schemes, consumer spending on medicines is expected to increase, which will spur growth in the generic sector in the domestic market.
The manufacturing-units of Aarti Drugs Ltd. are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all its units and one of the units has already been approved.
The Company aims at becoming the first choice of this expanding market through better products, ensuring quality and timely delivery.
Business area of the company
The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited.
Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.
Awards and accolades